AtriCure
ATRC
108 hedge funds and large institutions have $834M invested in AtriCure in 2018 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 48 increasing their positions, 33 reducing their positions, and 9 closing their positions.
45% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 33
32% more capital invested
Capital invested by funds: $630M → $834M (+$204M)
0% more funds holding
Funds holding: 108 → 108 (0)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 9
0.86% less ownership
Funds ownership: 88.82% → 87.96% (-0.86%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$21.1M |
| 2 |
OAM
Oberweis Asset Management
Lisle,
Illinois
|
+$5.33M |
| 3 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$5M |
| 4 |
BlackRock
New York
|
+$3.87M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
+$3.65M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$30.6M |
| 2 |
Millennium Management
New York
|
-$12.3M |
| 3 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$5.76M |
| 4 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
-$4.01M |
| 5 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$2.68M |
ATRC Hedge Fund Activity: Q2 2018 in Review
108 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q2 2018, worth a combined $834M — up 32% from $630M a quarter earlier.
Fund positioning in ATRC was balanced in Q2 2018: 9 funds opened new positions, 9 closed out, 48 added to existing stakes and 33 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $21.1M. The largest seller was Wellington Management Group, cutting an estimated $30.6M.
- 108 institutional investors held AtriCure (ATRC) as of Q2 2018, unchanged from Q1 2018.
- Funds reported $834M of AtriCure stock for Q2 2018, up 32% quarter-over-quarter.
- 9 funds opened new AtriCure positions in Q2 2018 and 9 closed out, a net change of 0 holders.
- The largest AtriCure buyer in Q2 2018 was T. Rowe Price Associates, an estimated $21.1M added.
- The largest AtriCure seller in Q2 2018 was Wellington Management Group, an estimated $30.6M sold.
Based on aggregated 13F filings for Q2 2018.